This was corroborated in a recent study of large vessel occlusion (LVO) ischemic stroke, where plasma BD‐tau displayed higher discriminative performance for 3‐month functional outcome than GFAP, NfL, and total‐Tau [31]. This evidence concerns the gene NEFL and ischemic stroke.